My JEMPERLI Journey

Newly-diagnosed advanced or returned endometrial cancer (EC) can be overwhelming, leaving you unsure of what the future holds. This diagnosis will impact the lives of the patient, their loved ones, and healthcare providers.

The videos below tell the story of Cheryl, a patient newly-diagnosed with EC that has spread (advanced), who is starting JEMPERLI + carboplatin and paclitaxel (CP) treatments, through three different, yet connected, perspectives.

  • We follow Cheryl through the uncertainty brought on by her symptoms and the feeling of helplessness surrounding her initial diagnosis, to the support of her loved ones and her healthcare team as she navigates her disease journey and learns about JEMPERLI + CP as a treatment option
  • We witness Teena, Cheryl's daughter, a wife and mother with a full-time job, as she navigates the ups and downs as Cheryl's primary care partner
  • We meet Susan, the compassionate infusion nurse who dedicates herself to providing exceptional care for patients, including Cheryl

These videos are inspired by several patients and are not representative of a single person’s story. Individual experiences will vary.

It’s your turn to take up space

Help make endometrial cancer impossible to ignore.

By becoming a JEMPERLI Ambassador, you can raise awareness about endometrial cancer and help create a space where women feel supported and understood. Sharing your experience can give another woman the strength to share hers. Each story opens the door for the next.

Connect With Us

Shine a light on Cheryl’s JEMPERLI Journey

Follow Cheryl as she copes with her EC diagnosis, leans on her loved ones, and starts her treatment with JEMPERLI + CP.

transcript

Graphic: JEMPERLI LOGO

NARRATOR:

Approved Uses

JEMPERLI is a prescription medicine used to treat adults with:

  • a kind of uterine cancer called endometrial cancer (EC)

    • JEMPERLI may be used in combination with the chemotherapy medicines, carboplatin and paclitaxel, and then after that JEMPERLI may be used alone:

      • when your cancer has spread outside your uterus (advanced) or,
      • your cancer has returned.
    • JEMPERLI may be used alone:

      • when a laboratory test shows that your tumor is mismatch repair deficient (dMMR), and
      • your cancer has returned, or it has spread (advanced EC), and
      • you have received chemotherapy that contains platinum and it did not work or is no longer working, and
      • your cancer cannot be treated by surgery or radiation.

It is not known if JEMPERLI is safe and effective in children.

Important Safety Information

JEMPERLI is a medicine that may treat certain cancers by working with your immune system. JEMPERLI can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.

Please continue watching for additional Important Safety Information later in this video. Please see full Prescribing Information, including Medication Guide for patients at adjacent links on this page or visit JEMPERLI.com.

CHERYL:
      I knew something was wrong. I was searching high and low for answers about my abnormal spotting and pelvic pain, but I wasn’t finding any. I felt like I wasn’t being heard. I felt invisible.
     Finally, I got my answer. And it was devastating. Cancer. Endometrial cancer. Stage III.
Once I got diagnosed everything moved so fast. I felt lost. There was so much information, things I’d never known, words I'd never heard before. I barely had time to register that I had cancer.
      I felt overwhelmed. People around me didn’t know what to do. I knew my family and friends wanted to help but they didn’t know how. I didn’t realize that having advanced endometrial cancer would make me feel so isolated. It's like I’m not myself anymore, or worse, that I'm just my diagnosis.
      But tomorrow is a new day. I’m starting chemotherapy along with another treatment, an immunotherapy that may work with my body to help fight cancer. I’m going to let myself have hope that it may help me.
      I couldn't do this without my care team and I couldn't do this without my daughter Teena either. They helped me feel confident as I started my treatment with the immunotherapy JEMPERLI in combination with carboplatin and paclitaxel. I felt like I had a good idea of what to expect when it came to the dosing schedule and possible side effects.
      Teena has been my rock. She stays in contact with my care team to keep my healthcare visits and infusion appointments on track. She also reminds me to celebrate the good things in life. Teena is already talking about attending my grandson’s graduation. I know nothing is certain, but hopefully I can watch him cross that stage.
      Endometrial cancer is scary, but I’ve found a care team I trust and an endometrial cancer community that supports me. With JEMPERLI, I’ve found a treatment option that is right for me. My road hasn’t been easy, but I realize I have an inner strength I didn’t know I had. And every day I’m finding more of me.
      This is my JEMPERLI journey!

[JEMPERLI LOGO]

NARRATOR:

Call or see your healthcare provider (HCP) right away if you develop any new or worsening signs or symptoms, including:

Lung problems. Signs and symptoms may include cough, shortness of breath, or chest pain.

Intestinal problems. Signs and symptoms may include diarrhea or more bowel movements than usual; stools that are black, tarry, sticky, or have blood or mucus; or severe stomach-area (abdomen) pain or tenderness.

Liver problems. Signs and symptoms may include yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), dark urine (tea colored), or bleeding or bruising more easily than usual.

Hormone gland problems. Signs and symptoms may include headaches that will not go away or unusual headaches, eye sensitivity to light, eye problems, rapid heartbeat, increased sweating, extreme tiredness, weight gain or weight loss, feeling more hungry or thirsty than usual, urinating more often than usual, hair loss, feeling cold, constipation, your voice gets deeper, dizziness or fainting, changes in mood or behavior such as decreased sex drive, irritability, or forgetfulness.

Kidney problems. Signs and symptoms may include change in the amount or color of your urine, blood in your urine, swelling in your ankles, or loss of appetite.

Skin problems. Signs and symptoms may include rash; itching; skin blistering or peeling; swollen lymph nodes; painful sores or ulcers in your mouth or in your nose, throat, or genital area; fever or flu-like symptoms.

Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen with JEMPERLI. Call or see your HCP right away for any new or worse signs or symptoms. Signs and symptoms may include chest pain, irregular heartbeat, shortness of breath, swelling of ankles; confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs; double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight; persistent or severe muscle pain or weakness, muscle cramps; low red blood cells, bruising.

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, feel like passing out, fever, back or neck pain.

Rejection of a transplanted organ. Your HCP should tell you what signs and symptoms you should report and monitor you, depending on the type of organ transplant that you have had.

Complications, including graft-versus-host-disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with JEMPERLI. Your HCP will monitor you for these complications. 

Getting medical treatment right away may help keep these problems from becoming more serious. Your HCP will check you for these problems during treatment with JEMPERLI and may treat you with corticosteroid or hormone replacement medicines. If you have severe side effects, your HCP may also need to delay or completely stop treatment with JEMPERLI. 

Before receiving JEMPERLI, tell your HCP about all of your medical conditionsincluding immune system problems such as Crohn’s disease, ulcerative colitis, or lupus; received an organ transplant; have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic); have received radiation treatment to your chest area; have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome.  

If you are pregnant or plan to become pregnant, tell your HCP. JEMPERLI can harm your unborn baby. If you are able to become pregnant, your HCP will give you a pregnancy test before you start treatment. Use an effective birth control method during treatment and for 4 months after your last dose of JEMPERLI. Tell your HCP right away if you become pregnant or think you may be pregnant during treatment with JEMPERLI.

If you are breastfeeding or plan to breastfeed, tell your HCP. It is not known if JEMPERLI passes into your breast milk. Do not breastfeed during treatment with JEMPERLI and for 4 months after your last dose.      

Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

The most common side effects of JEMPERLI when given with carboplatin and paclitaxel include nerve problems in your arms, hands, legs, and feet; tiredness; nausea; hair loss; joint pain; rash; constipation; diarrhea; stomach-area (abdomen) pain; shortness of breath; decreased appetite; urinary tract infections; vomiting.

The most common side effects of JEMPERLI when used alone include tiredness and weakness, low red blood cell count (anemia), diarrhea, nausea, constipation, vomiting.

These are not all of the possible side effects of JEMPERLI. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report negative side effects to GSK at www.gsk.public.reportum.com or 1-888-825-5249. 

Please see full Prescribing Information, including Medication Guide for patients on this page or at JEMPERLI.com.

[JEMPERLI LOGO]

NARRATOR:
Speak to your doctor and discover how JEMPERLI may help you.

Visit JEMPERLI.COM

[JEMPERLI LOGO]
[GSK LOGO]

For US audiences only.
Trademarks are owned by or licensed to the GSK group of companies.

©2025 GSK or licensor
PMUS-DSTVID240005 March 2025
Produced in USA.

Follow Teena’s role as Cheryl’s care partner

Teena navigates the ups and downs of being a care partner for her mother, Cheryl.

transcript

Graphic: JEMPERLI LOGO

NARRATOR:

Approved Uses

JEMPERLI is a prescription medicine used to treat adults with:

  • a kind of uterine cancer called endometrial cancer (EC) 

    • JEMPERLI may be used in combination with the chemotherapy medicines, carboplatin and paclitaxel, and then after that JEMPERLI may be used alone:

      • when your cancer has spread outside your uterus (advanced) or,
      • your cancer has returned.
    • JEMPERLI may be used alone:

      • when a laboratory test shows that your tumor is mismatch repair deficient (dMMR), and
      • your cancer has returned, or it has spread (advanced EC), and
      • you have received chemotherapy that contains platinum and it did not work or is no longer working, and
      • your cancer cannot be treated by surgery or radiation.

It is not known if JEMPERLI is safe and effective in children.

Important Safety Information

JEMPERLI is a medicine that may treat certain cancers by working with your immune system. JEMPERLI can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.

Please continue watching for additional Important Safety Information later in this video. Please see full Prescribing Information, including Medication Guide for patients at adjacent links on this page or visit JEMPERLI.com.

Teena:
    I was driving my son to school one morning when I got a call from my mom. That call changed our lives from that day on. My mom said she was diagnosed with Stage 3 endometrial cancer. I was shocked and confused. I didn't even know what endometrial cancer was. But as soon as I saw her, I knew it was serious.
    Once I looked up endometrial cancer, I discovered that it is the most common gynecologic cancer, and some cases can be aggressive. I couldn’t help but wonder if there was anything I could’ve done differently to help her get diagnosed sooner.
    I knew my mom wasn’t herself, but whenever we tried to talk to her, she would just say she’s fine. It was clear to me she didn't want to be a burden. So my husband Charlie and I did our best to stay positive and supportive. One day she mentioned a treatment option her doctor told her about called JEMPERLI, which she would receive in combination with the chemotherapy medicines carboplatin and paclitaxel.
    We looked it up and discovered that JEMPERLI is an immunotherapy that may work with my mother’s body to help fight cancer. The doctor explained how JEMPERLI in combination with carboplatin and paclitaxel works. She also walked us through what my mom could expect about dosage and potential side effects.
    I want the best for my mom — her health and happiness are my priorities. But it’s not easy, and it can be a lot of work. As a wife and mother with a full-time job, I have a lot of responsibilities. Taking care of my mom on top of all of my commitments can be very stressful, and sometimes I feel alone.
    After speaking with my own doctor, I remind myself each day how important my own well-being is, not just for me, but for everyone who relies on me, including my mom. Her diagnosis has taught me not to be afraid to ask people for help. Nobody can do everything on their own, and there’s no shame in admitting that. Thankfully, after a couple of hard conversations, my husband and son have really stepped up, enabling me to be mindful of myself, and take the time to take a breath. Now I can focus on trying to keep my mom in good spirits and celebrating positive moments, however big or small.
    Thankfully, her nurses and doctors are always available to answer questions and provide her with support at each appointment. We know that my mom’s endometrial cancer will be a struggle, but with JEMPERLI, my mom has a way to potentially fight back. We have hope that she will be able to attend Max's middle school graduation.
    Taking care of someone with endometrial cancer can be difficult, especially when you have so many responsibilities of your own. But even though it’s not easy, I will always cherish spending time with my mom as her inner strength continues to shine through.
This is Our JEMPERLI Journey!

 

[JEMPERLI LOGO]

NARRATOR:

Call or see your healthcare provider (HCP) right away if you develop any new or worsening signs or symptoms, including:

Lung problems. Signs and symptoms may include cough, shortness of breath, or chest pain.

Intestinal problems. Signs and symptoms may include diarrhea or more bowel movements than usual; stools that are black, tarry, sticky, or have blood or mucus; or severe stomach-area (abdomen) pain or tenderness.

Liver problems. Signs and symptoms may include yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), dark urine (tea colored), or bleeding or bruising more easily than usual.

Hormone gland problems. Signs and symptoms may include headaches that will not go away or unusual headaches, eye sensitivity to light, eye problems, rapid heartbeat, increased sweating, extreme tiredness, weight gain or weight loss, feeling more hungry or thirsty than usual, urinating more often than usual, hair loss, feeling cold, constipation, your voice gets deeper, dizziness or fainting, changes in mood or behavior such as decreased sex drive, irritability, or forgetfulness.

Kidney problems. Signs and symptoms may include change in the amount or color of your urine, blood in your urine, swelling in your ankles, or loss of appetite.

Skin problems. Signs and symptoms may include rash; itching; skin blistering or peeling; swollen lymph nodes; painful sores or ulcers in your mouth or in your nose, throat, or genital area; fever or flu-like symptoms.

Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen with JEMPERLI. Call or see your HCP right away for any new or worse signs or symptoms. Signs and symptoms may include chest pain, irregular heartbeat, shortness of breath, swelling of ankles; confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs; double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight; persistent or severe muscle pain or weakness, muscle cramps; low red blood cells, bruising.

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, feel like passing out, fever, back or neck pain.

Rejection of a transplanted organ. Your HCP should tell you what signs and symptoms you should report and monitor you, depending on the type of organ transplant that you have had.

Complications, including graft-versus-host-disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with JEMPERLI. Your HCP will monitor you for these complications.

Getting medical treatment right away may help keep these problems from becoming more serious. Your HCP will check you for these problems during treatment with JEMPERLI and may treat you with corticosteroid or hormone replacement medicines. If you have severe side effects, your HCP may also need to delay or completely stop treatment with JEMPERLI.

Before receiving JEMPERLI, tell your HCP about all of your medical conditions, including immune system problems such as Crohn’s disease, ulcerative colitis, or lupus; received an organ transplant; have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic); have received radiation treatment to your chest area; have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome. 

If you are pregnant or plan to become pregnant, tell your HCP. JEMPERLI can harm your unborn baby. If you are able to become pregnant, your HCP will give you a pregnancy test before you start treatment. Use an effective birth control method during treatment and for 4 months after your last dose of JEMPERLI. Tell your HCP right away if you become pregnant or think you may be pregnant during treatment with JEMPERLI.

If you are breastfeeding or plan to breastfeed, tell your HCP. It is not known if JEMPERLI passes into your breast milk. Do not breastfeed during treatment with JEMPERLI and for 4 months after your last dose.      

Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

The most common side effects of JEMPERLI when given with carboplatin and paclitaxel include nerve problems in your arms, hands, legs, and feet; tiredness; nausea; hair loss; joint pain; rash; constipation; diarrhea; stomach-area (abdomen) pain; shortness of breath; decreased appetite; urinary tract infections; vomiting.

The most common side effects of JEMPERLI when used alone include tiredness and weakness, low red blood cell count (anemia), diarrhea, nausea, constipation, vomiting.

These are not all of the possible side effects of JEMPERLI. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report negative side effects to GSK at www.gsk.public.reportum.com or 1-888-825-5249. 

Please see full Prescribing Information, including Medication Guide for patients on this page or at JEMPERLI.com.

[JEMPERLI LOGO]

NARRATOR:
Help is available for care partners like you.

Visit www.JEMPERLI.com/endometrial-cancer/care-partners

[JEMPERLI LOGO]
[GSK LOGO]

For US audiences only.
Trademarks are owned by or licensed to the GSK group of companies.

©2025 GSK or licensor
PMUS-DSTVID250008 October 2025
Produced in USA.

See how Susan supports Cheryl as her nurse

Susan, an infusion nurse who goes above and beyond for patients like Cheryl, provides medical care and a human connection.

transcript

[JEMPERLI LOGO]

NARRATOR:

Approved Uses

JEMPERLI is a prescription medicine used to treat adults with:

  • a kind of uterine cancer called endometrial cancer (EC) 

    • JEMPERLI may be used in combination with the chemotherapy medicines, carboplatin and paclitaxel, and then after that JEMPERLI may be used alone:

      • when your cancer has spread outside your uterus (advanced) or,
      • your cancer has returned.
    • JEMPERLI may be used alone:

      • when a laboratory test shows that your tumor is mismatch repair deficient (dMMR), and
      • your cancer has returned, or it has spread (advanced EC), and
      • you have received chemotherapy that contains platinum and it did not work or is no longer working, and
      • your cancer cannot be treated by surgery or radiation.

It is not known if JEMPERLI is safe and effective in children.

Important Safety Information

JEMPERLI is a medicine that may treat certain cancers by working with your immune system. JEMPERLI can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.

Please continue watching for additional Important Safety Information later in this video. Please see full Prescribing Information, including Medication Guide for patients at adjacent links on this page or visit JEMPERLI.com.

SUSAN:
    
 I’ve been an oncology nurse for 12 years, specializing in gynecological cancer care. I knew going in that working with people with cancer would be tough – each day brings its own set of challenges. Cancer is a scary diagnosis to be confronted with.
    Each patient I work with is different, and each treatment journey is unique, including my patients with endometrial cancer. Some of my patients told me they knew something was wrong but they weren't sure how to talk about it, so it took a while to get to a diagnosis. And when they did, they felt invisible since their family and friends don't know much about endometrial cancer, or how to help them. Like Cheryl. I could tell she was struggling with her diagnosis. She felt so alone, even though her family and friends wanted to help.
    As a nurse, I knew I could help her feel more empowered by educating her and her care partner about her endometrial cancer and her treatment plan discussing resources she may find helpful, and encouraging her through each step of the journey. I was able to shed some light on an immunotherapy she would be taking, called JEMPERLI, in addition to the chemotherapy medications carboplatin and paclitaxel. This is why I love what I do. I help patients like Cheryl and their care partners understand what to expect with JEMPERLI, and do my best to make them and their care partners feel confident and hopeful through education and support.
    I’ve got a lot of responsibilities, and my day-to-day can be overwhelming, with not a lot of time for myself. But being able to support patients through such a difficult time and connecting with and encouraging them through their journey makes it all worth it. Each time Cheryl comes in for her treatment, I’m reminded why I do what I do. Over time, I saw her confidence grow as she started to better understand and become more familiar with her treatment plan. As a nurse, I'm proud of my work educating and supporting patients.
    This Is Our JEMPERLI Journey!

NARRATOR:

Call or see your healthcare provider (HCP) right away if you develop any new or worsening signs or symptoms, including:

Lung problems. Signs and symptoms may include cough, shortness of breath, or chest pain.

Intestinal problems. Signs and symptoms may include diarrhea or more bowel movements than usual; stools that are black, tarry, sticky, or have blood or mucus; or severe stomach-area (abdomen) pain or tenderness.

Liver problems. Signs and symptoms may include yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), dark urine (tea colored), or bleeding or bruising more easily than usual.

Hormone gland problems. Signs and symptoms may include headaches that will not go away or unusual headaches, eye sensitivity to light, eye problems, rapid heartbeat, increased sweating, extreme tiredness, weight gain or weight loss, feeling more hungry or thirsty than usual, urinating more often than usual, hair loss, feeling cold, constipation, your voice gets deeper, dizziness or fainting, changes in mood or behavior such as decreased sex drive, irritability, or forgetfulness.

Kidney problems. Signs and symptoms may include change in the amount or color of your urine, blood in your urine, swelling in your ankles, or loss of appetite.

Skin problems. Signs and symptoms may include rash; itching; skin blistering or peeling; swollen lymph nodes; painful sores or ulcers in your mouth or in your nose, throat, or genital area; fever or flu-like symptoms.

Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen with JEMPERLI. Call or see your HCP right away for any new or worse signs or symptoms. Signs and symptoms may include chest pain, irregular heartbeat, shortness of breath, swelling of ankles; confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs; double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight; persistent or severe muscle pain or weakness, muscle cramps; low red blood cells, bruising.

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, feel like passing out, fever, back or neck pain.

Rejection of a transplanted organ. Your HCP should tell you what signs and symptoms you should report and monitor you, depending on the type of organ transplant that you have had.

Complications, including graft-versus-host-disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with JEMPERLI. Your HCP will monitor you for these complications.

Getting medical treatment right away may help keep these problems from becoming more serious. Your HCP will check you for these problems during treatment with JEMPERLI and may treat you with corticosteroid or hormone replacement medicines. If you have severe side effects, your HCP may also need to delay or completely stop treatment with JEMPERLI.

Before receiving JEMPERLI, tell your HCP about all of your medical conditions, including immune system problems such as Crohn’s disease, ulcerative colitis, or lupus; received an organ transplant; have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic); have received radiation treatment to your chest area; have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome. 

If you are pregnant or plan to become pregnant, tell your HCP. JEMPERLI can harm your unborn baby. If you are able to become pregnant, your HCP will give you a pregnancy test before you start treatment. Use an effective birth control method during treatment and for 4 months after your last dose of JEMPERLI. Tell your HCP right away if you become pregnant or think you may be pregnant during treatment with JEMPERLI.

If you are breastfeeding or plan to breastfeed, tell your HCP. It is not known if JEMPERLI passes into your breast milk. Do not breastfeed during treatment with JEMPERLI and for 4 months after your last dose.

Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

The most common side effects of JEMPERLI when given with carboplatin and paclitaxel include nerve problems in your arms, hands, legs, and feet; tiredness; nausea; hair loss; joint pain; rash; constipation; diarrhea; stomach-area (abdomen) pain; shortness of breath; decreased appetite; urinary tract infections; vomiting.

The most common side effects of JEMPERLI when used alone include tiredness and weakness, low red blood cell count (anemia), diarrhea, nausea, constipation, vomiting.

These are not all of the possible side effects of JEMPERLI. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report negative side effects to GSK at www.gsk.public.reportum.com or 1-888-825-5249. 

Please see full Prescribing Information, including Medication Guide for patients at nearby links on this page or at JEMPERLI.com.

[JEMPERLI LOGO]

NARRATOR:

Discover JEMPERLI Patient Resources.

Visit JEMPERLI.COM

[JEMPERLI LOGO]
[GSK LOGO]

For US audiences only.
Trademarks are owned by or licensed to the GSK group of companies.

©2025 GSK or licensor
PMUS-DSTVID250002 July 2025
Produced in USA.

.

JEMPERLI + carboplatin and paclitaxel (CP) for newly-diagnosed advanced or returned endometrial cancer

Learn more about the clinical trial that studied JEMPERLI + CP for newly-diagnosed advanced or returned endometrial cancer.

See Study Results

.

JEMPERLI alone for advanced or returned dMMR endometrial cancer

If you or your loved one has been diagnosed with advanced or returned dMMR (mismatch repair deficient) endometrial cancer, learn more about how JEMPERLI may help.

Get the Details

.

For Care Partners

Learn how you can support your loved one throughout their journey.

Learn More

.

For Nurses

Learn about Dosing and Administration for JEMPERLI.

How JEMPERLI is Given

Let's hear from you